Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Vieth

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Biochimica Et Biophysica Acta|December 17, 2009
Structure-guided expansion of kinase fragment libraries driven by support vector machine modelsJon A Erickson, Mary M Mader, Ian A Watson, et al.
Biochimica Et Biophysica Acta|April 12, 2015
Perspective on computational and structural aspects of kinase discovery from IPK2014Eric Martin, Stefan Knapp, Richard A Engh, et al.
Plos One|April 14, 2017
Reconstruction of 3D structures of MET antibodies from electron microscopy 2D class averagesQi Chen, Michal Vieth, David E Timm, et al.
Journal of Medicinal Chemistry|December 30, 2003
Characteristic physical properties and structural fragments of marketed oral drugsMichal Vieth, Miles G Siegel, Richard E Higgs, et al.
Plos One|November 19, 2013
A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosisAnuradha Kumar, Allen Casey, Joshua Odingo, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosisJulie V Early, Allen Casey, Maria Angeles Martinez-Grau, et al.
Molecular Cancer Therapeutics|November 22, 2017
Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab ResistanceAtrish Bagchi, Jaafar N Haidar, Scott W Eastman, et al.
Journal of Medicinal Chemistry|September 5, 2003
Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domainJ Scott Sawyer, Bryan D Anderson, Douglas W Beight, et al.
Nature Chemical Biology|July 22, 2020
Structural insights into probe-dependent positive allosterism of the GLP-1 receptorAna B Bueno, Bingfa Sun, Francis S Willard, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluationCarlos Jaramillo, J Eugenio de Diego, Chafiq Hamdouchi, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|December 17, 2009
Structure-guided expansion of kinase fragment libraries driven by support vector machine modelsJon A Erickson, Mary M Mader, Ian A Watson, et al.
Biochimica Et Biophysica Acta|April 12, 2015
Perspective on computational and structural aspects of kinase discovery from IPK2014Eric Martin, Stefan Knapp, Richard A Engh, et al.
Plos One|April 14, 2017
Reconstruction of 3D structures of MET antibodies from electron microscopy 2D class averagesQi Chen, Michal Vieth, David E Timm, et al.
Journal of Medicinal Chemistry|December 30, 2003
Characteristic physical properties and structural fragments of marketed oral drugsMichal Vieth, Miles G Siegel, Richard E Higgs, et al.
Plos One|November 19, 2013
A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosisAnuradha Kumar, Allen Casey, Joshua Odingo, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosisJulie V Early, Allen Casey, Maria Angeles Martinez-Grau, et al.
Molecular Cancer Therapeutics|November 22, 2017
Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab ResistanceAtrish Bagchi, Jaafar N Haidar, Scott W Eastman, et al.
Journal of Medicinal Chemistry|September 5, 2003
Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domainJ Scott Sawyer, Bryan D Anderson, Douglas W Beight, et al.
Nature Chemical Biology|July 22, 2020
Structural insights into probe-dependent positive allosterism of the GLP-1 receptorAna B Bueno, Bingfa Sun, Francis S Willard, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2004
Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluationCarlos Jaramillo, J Eugenio de Diego, Chafiq Hamdouchi, et al.
Pageof 4